Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease

Apolipoprotein A-V associates with intrahepatic lipid droplets and influences triglyceride accumulation

(2010) Xiao Shu et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype

(2010) Chunyu Zheng et al.   CIRCULATION

Cardiovascular Death in Dialysis Patients: Lessons We Can Learn from AURORA

(2010) A. D. Sniderman et al.   Clinical Journal of the American Society of Nephrology

Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions

(2009) M. Sundaram et al.   JOURNAL OF LIPID RESEARCH

Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III

(2009) Doris T. Chan et al.   JOURNAL OF LIPID RESEARCH

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor

(2008) Esther M. M. Ooi et al.   CLINICAL SCIENCE

Dose-Dependent Effect of Rosuvastatin on VLDL-Apolipoprotein C-III Kinetics in the Metabolic Syndrome

(2008) E. M.M. Ooi et al.   DIABETES CARE

Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials

(2007) Doris T. Chan et al.   ATHEROSCLEROSIS

Plasma Apolipoprotein C-III Transport in Centrally Obese Men: Associations with Very Low-Density Lipoprotein Apolipoprotein B and High-Density Lipoprotein Apolipoprotein A-I Metabolism

(2007) Dick C. Chan et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM